The Ritedose Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1 Technology Circle, Columbia, South Carolina (SC) 29203, United States (USA)
- Operations here
- analysislabelmanufacturepackrepack
- FDA identifiers
- FEI 3001237796 · DUNS 837769546
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-02-28
- VAIDrug Quality Assurance2022-03-22
- NAIBioresearch Monitoring2019-04-18
- VAIDrug Quality Assurance2017-03-03
- VAIDrug Quality Assurance2015-07-31
- NAIDrug Quality Assurance2014-04-17
- NAIDrug Quality Assurance2012-11-08
- NAIDrug Quality Assurance2011-09-09
- VAIDrug Quality Assurance2011-01-06
- NAIBioresearch Monitoring2010-09-30
- NAIDrug Quality Assurance2010-08-12
- NAIDrug Quality Assurance2009-09-18
Drugs this plant is listed as making
7 distinct drugs across 14 products name this site in their FDA label.
- Arformoterol Tartrate Inhalation SolutionRitedose Pharmaceuticals, LLC
- budesonide inhalationLupin Pharmaceuticals, Inc.
- ensifentrineMerck Sharp & Dohme Llc
- formoterol fumarate dihydrateRitedose Pharmaceuticals, LLC
- Ipratropium Bromide and Albuterol SulfateGolden State Medical Supply, Inc.
- Levalbuterol HydrochlorideRitedose Pharmaceuticals, LLC
- LifitegrastNovartis Pharmaceuticals Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.